NASDAQ:TANGO 6 March 2026 - 8 June 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics shares rose in premarket trading Monday. The company posted positive early results for its pancreatic cancer drug combo and said it aims to advance the treatment into late-stage trials.

8 June 2026

NASDAQ:RVMD·NASDAQ:TANGO·Stock Market

Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics surged about 36% Thursday, propelled by fourth-quarter numbers and news of a fresh partnership with Erasca to study vopimetostat—the company’s lead drug—in pancreatic and lung cancer settings. Shares recently changed hands at $16.83.

6 March 2026

NASDAQ:ERAS·NASDAQ:TANGO·Pharmaceutical Industry·Stock Market

Go toTop